Výsledky vyhledávání - "Larry Charleston"

Akademický článek

Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review

Autor: Andrew M. Blumenfeld, Richard B. Lipton, Stephen Silberstein, Stewart J. Tepper, Larry Charleston, Stephen Landy, Deena E. Kuruvilla, Aubrey Manack Adams

Publikováno v: Neurology and Therapy, Vol 12, Iss 5, Pp 1533-1551 (2023)

Abstract Migraine is a neurologic disease with a complex pathophysiology that can be controlled with current treatment options but not cured. Therefore, treatment expectations are highly variable. The concept of migraine freedom was recently introduc

Externí odkaz: https://doaj.org/article/bb3f6e1700ef433e92ce463429385b39

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

Autor: Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, Stephanie J. Nahas

Publikováno v: The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)

Abstract Background To date, real-world evidence on persistence to anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies (mAbs) or onabotulinumtoxinA have excluded eptinezumab. This retrospective cohort study was performed to compare

Externí odkaz: https://doaj.org/article/bb268687fead4cd98685986f0097f51f

Zobrazit plný text záznamu

Akademický článek

Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials

Autor: Richard B. Lipton, Larry Charleston, Cristina Tassorelli, Thomas Brevig, Joe Hirman, Roger Cady

Publikováno v: The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-12 (2022)

Abstract Background PROMISE-1 and PROMISE-2 evaluated the preventive efficacy, tolerability, and safety of eptinezumab, a calcitonin gene-related peptide–targeted monoclonal antibody, in adults with episodic (EM) and chronic migraine (CM), finding

Externí odkaz: https://doaj.org/article/c94fa50a89d741ac9a1251b483d856d5

Zobrazit plný text záznamu

Akademický článek

Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine

Autor: Dawn C. Buse, Paul K. Winner, Larry Charleston, Joe Hirman, Roger Cady, Thomas Brevig

Publikováno v: The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-12 (2022)

Abstract Background A clinical ability to describe the response trajectory of patients receiving preventive migraine treatment could expedite and improve therapeutic management decisions. This post hoc analysis of the PROMISE-2 study evaluated the co

Externí odkaz: https://doaj.org/article/5115f9d7b341495eb41d3dac23d97a10

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání